Endoscopic resection of large anastomotic polyps is safe and effective.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
10 Nov 2023
Historique:
pubmed: 13 9 2023
medline: 13 9 2023
entrez: 12 9 2023
Statut: aheadofprint

Résumé

Large (≥20mm) adenomatous anastomotic polyps (LAAPs) are uncommon. Data pertaining to their prevalence, characteristics, and the efficacy of endoscopic resection (ER) are absent. A safe and effective strategy for ER would reduce morbidity and healthcare costs. Large nonpedunculated colorectal polyps of ≥20mm (LNPCPs) referred for ER were prospectively studied. Multiple data points were recorded including anastomotic location, polyp morphology, resection modality, complications, and technical success. Over 7 years until November 2022, 2629 lesions were referred. Of these, 10 (0.4%) were LAAPs (median size 35 mm [interquartile range (IQR) 30-40mm]). All LAAPs were removed by piecemeal endoscopic mucosal resection (EMR), most (n=9; 90%) in combination with cold-forceps avulsion with adjuvant snare-tip soft coagulation (CAST). On comparison of the LAAP group with the conventional LNPCP group, CAST was more commonly used (90% vs. 9%; LAAPs present unique challenges owing to their location overlying an anastomosis. Despite these challenges they can be safely and effectively managed endoscopically without recurrence at endoscopic follow-up.

Sections du résumé

BACKGROUND BACKGROUND
Large (≥20mm) adenomatous anastomotic polyps (LAAPs) are uncommon. Data pertaining to their prevalence, characteristics, and the efficacy of endoscopic resection (ER) are absent. A safe and effective strategy for ER would reduce morbidity and healthcare costs.
METHODS METHODS
Large nonpedunculated colorectal polyps of ≥20mm (LNPCPs) referred for ER were prospectively studied. Multiple data points were recorded including anastomotic location, polyp morphology, resection modality, complications, and technical success.
RESULTS RESULTS
Over 7 years until November 2022, 2629 lesions were referred. Of these, 10 (0.4%) were LAAPs (median size 35 mm [interquartile range (IQR) 30-40mm]). All LAAPs were removed by piecemeal endoscopic mucosal resection (EMR), most (n=9; 90%) in combination with cold-forceps avulsion with adjuvant snare-tip soft coagulation (CAST). On comparison of the LAAP group with the conventional LNPCP group, CAST was more commonly used (90% vs. 9%;
CONCLUSIONS CONCLUSIONS
LAAPs present unique challenges owing to their location overlying an anastomosis. Despite these challenges they can be safely and effectively managed endoscopically without recurrence at endoscopic follow-up.

Identifiants

pubmed: 37699523
doi: 10.1055/a-2174-2967
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

M. Bourke has received research support from Olympus Medical, Cook Medical, and Boston Scientific. O. Cronin, S. Gupta, J. Gauci, A. Whitfield, T. O'Sullivan, M. Abuarisha, H. Wang, E. Lee, S. Williams, and N.G. Burgess declare that they have no conflict of interest.

Auteurs

Oliver Cronin (O)

Gastroenterology and Hepatology, Westmead Hospital, Westmead, Australia.
Medicine, The University of Sydney Westmead Clinical School, Sydney, Australia.

Sunil Gupta (S)

Gastroenterology and Hepatology, Westmead Hospital, Westmead, Australia.
Medicine, The University of Sydney Westmead Clinical School, Sydney, Australia.

Julia Gauci (J)

Gastroenterology and Hepatology, Westmead Hospital, Westmead, Australia.
Medicine, The University of Sydney Westmead Clinical School, Sydney, Australia.

Anthony Whitfield (A)

Gastroenterology and Hepatology, Westmead Hospital, Westmead, Australia.
Medicine, The University of Sydney Westmead Clinical School, Sydney, Australia.

Timothy O'Sullivan (T)

Gastroenterology and Hepatology, Westmead Hospital, Westmead, Australia.
Medicine, The University of Sydney Westmead Clinical School, Sydney, Australia.

Muhammad Abuarisha (M)

Gastroenterology and Hepatology, Westmead Hospital, Westmead, Australia.
Medicine, The University of Sydney Westmead Clinical School, Sydney, Australia.

Hunter Wang (H)

Gastroenterology and Hepatology, Westmead Hospital, Westmead, Australia.
Medicine, The University of Sydney Westmead Clinical School, Sydney, Australia.

Eric Yong Tat Lee (EYT)

Gastroenterology and Hepatology, Westmead Hospital, Westmead, Australia.
Medicine, The University of Sydney Westmead Clinical School, Sydney, Australia.

Stephen J Williams (SJ)

Gastroenterology and Hepatology, Westmead Hospital, Westmead, Australia.
Medicine, The University of Sydney Westmead Clinical School, Sydney, Australia.

Nicholas Graeme Burgess (NG)

Gastroenterology and Hepatology, Westmead Hospital, Westmead, Australia.
Medicine, The University of Sydney Westmead Clinical School, Sydney, Australia.

Michael J Bourke (MJ)

Gastroenterology and Hepatology, Westmead Hospital, Westmead, Australia.
Medicine, The University of Sydney Westmead Clinical School, Sydney, Australia.

Classifications MeSH